Evidence map›Paper›PMID 29967395›Full record

ArticleNature chemistry2018

A designer enzyme for hydrazone and oxime formation featuring an unnatural catalytic aniline residue.

Ivana Drienovská, Clemens Mayer, Christopher Dulson, Gerard Roelfes

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 174 citations in OpenAlex.

  1. Reprogramming NAD(P)Angewandte Chemie (International ed. in English) · 2026
    Article
  2. Article
  3. Building Molecules by a Self-Replicator That Catalyzes Acyl Hydrazone Formation.Angewandte Chemie (International ed. in English) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Designing Enzymatic Reactivity with an Expanded Palette.Chembiochem : a European journal of chemical biology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ivana DrienovskáStratingh Institute for Chemistry, University of Groningen, Groningen, the Netherlands.ORCID http://orcid.org/0000-0003-1715-4236
Clemens MayerStratingh Institute for Chemistry, University of Groningen, Groningen, the Netherlands.ORCID http://orcid.org/0000-0002-6495-9873
Christopher DulsonStratingh Institute for Chemistry, University of Groningen, Groningen, the Netherlands.
Gerard RoelfesStratingh Institute for Chemistry, University of Groningen, Groningen, the Netherlands. j.g.roelfes@rug.nl.ORCID http://orcid.org/0000-0002-0364-9564
University of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Creating designer enzymes with the ability to catalyse abiological transformations is a formidable challenge. Efforts toward this goal typically consider only canonical amino acids in the initial design process. However, incorporating unnatural amino acids that feature uniquely reactive side chains could significantly expand the catalytic repertoire of designer enzymes. To explore the potential of such artificial building blocks for enzyme design, here we selected p-aminophenylalanine as a potentially novel catalytic residue. We demonstrate that the catalytic activity of the aniline side chain for hydrazone and oxime formation reactions is increased by embedding p-aminophenylalanine into the hydrophobic pore of the multidrug transcriptional regulator from Lactococcus lactis. Both the recruitment of reactants by the promiscuous binding pocket and a judiciously placed aniline that functions as a catalytic residue contribute to the success of the identified artificial enzyme. We anticipate that our design strategy will prove rewarding to significantly expand the catalytic repertoire of designer enzymes in the future.

Indexed as

Aniline CompoundsATP-Binding Cassette, Sub-Family C ProteinsBacterial ProteinsBinding SitesBiocatalysisEnzymesHydrazonesHydrophobic and Hydrophilic InteractionsKineticsLactococcus lactisMolecular Dynamics SimulationMutagenesisOximesSulfatasesanilineAniline CompoundsATP-Binding Cassette, Sub-Family C ProteinsBacterial ProteinsEnzymesHydrazonesOximesSulfatases

Identifiers

PMID29967395
OpenAlexW2809896272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.